Delcath Systems, Inc. (DCTH): who owns it and who trades it
As of Nov 16, 2026, DCTH insiders reported 2 open-market sales worth $489K and 3 purchases worth $189K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Bridget A Martell (Director), with $489K. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Delcath Systems
From the latest filingsOverall: more buying than selling. Funds, insiders and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns DCTH
120 funds and institutions reported DCTH shares worth $220M at the end of Q2 2026, about 51% of the company. The largest holder is Rosalind Advisors, Inc. with 9.6%.
Funds and institutions (13F) 51%Everyone else 49%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 3.30M | 9.56% | $41.6M | No change |
| BlackRock, Inc. | 2.71M | 7.84% | $34.1M | +52% |
| Vanguard Capital Management LLC | 1.22M | 3.54% | $15.4M | -8% |
| Propel Bio Management, LLC | 871,460 | 2.52% | $11M | -11% |
| Geode Capital Management, LLC | 733,115 | 2.12% | $9.2M | +6% |
| State Street Corp | 679,280 | 1.97% | $8.6M | +2% |
| Algert Global LLC | 580,708 | 1.68% | $7.3M | +298% |
| Millennium Management LLC | 566,371 | 1.64% | $7.1M | -4% |
| Divisadero Street Capital Management, LP | 499,796 | 1.45% | $6.3M | No change |
| Morgan Stanley | 407,983 | 1.18% | $5.1M | +6% |
| ExodusPoint Capital Management, LP | 359,884 | 1.04% | $4.5M | +901% |
| Private Wealth Advisors, LLC | 310,863 | 0.90% | $3.9M | -47% |
| Simplify Asset Management Inc. | 264,770 | 0.77% | $3.3M | +1% |
| Northern Trust Corp | 252,108 | 0.73% | $3.2M | +0% |
| Goldman Sachs Group Inc | 250,312 | 0.73% | $3.2M | -13% |
| ADAR1 Capital Management, LLC | 224,385 | 0.65% | $2.8M | No change |
| Marshall Wace, LLP | 218,963 | 0.63% | $2.8M | +14% |
| Dimensional Fund Advisors LP | 210,298 | 0.61% | $2.6M | – |
| Kennedy Capital Management LLC | 204,143 | 0.59% | $2.6M | -2% |
| Vanguard Portfolio Management LLC | 193,448 | 0.56% | $2.4M | +9% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, DCTH insiders reported $189K of open-market purchases and $489K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Bridget A Martell | Director | Sale | 20,570 | $21.66 | $446K | Form 4 |
| Nov 12, 2026 | Bridget A Martell | Director | Sale | 1,930 | $22.26 | $43K | Form 4 |
| Mar 6, 2026 | Sandra Pennell | CFO | Purchase | 5,533 | $9.04 | $50K | Form 4 |
| Mar 2, 2026 | Gerard J Michel | CEO | Purchase | 11,200 | $8.96 | $100K | Form 4 |
| Nov 21, 2025 | John Richard Sylvester | Director | Purchase | 4,386 | $8.89 | $39K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Bridget A Martell | Director | – | $489K | Nov 12, 2026 |
| Gerard J Michel | CHIEF EXECUTIVE OFFICER, Director | $100K | – | Mar 2, 2026 |
| Sandra Pennell | Chief Financial Officer | $50K | – | Mar 6, 2026 |
| John Richard Sylvester | Director | $39K | – | Nov 21, 2025 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
DCTH short interest
Moderate short interest. 5.1% of DCTH shares are sold short: about 1 share in 20. Over the last 12 reports the number of shares short went down 48%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 1.78M DCTH shares were sold short, 5.1% of the shares outstanding, down 5.7% from the report before. At the average daily volume of 309,358 shares, buying them all back would take about 5.7 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.78M | 5.10% | -6% | 309,358 | 5.7 |
| Oct 15, 2026 | 1.88M | 5.43% | -3% | 301,743 | 6.2 |
| Sep 30, 2026 | 1.95M | 5.61% | -16% | 362,508 | 5.4 |
| Sep 15, 2026 | 2.31M | 6.66% | +3% | 333,710 | 6.9 |
| Aug 31, 2026 | 2.24M | 6.46% | -5% | 451,440 | 5.0 |
| Aug 14, 2026 | 2.36M | 6.79% | -7% | 1.03M | 2.3 |
| Jul 31, 2026 | 2.53M | 7.30% | -6% | 350,263 | 7.2 |
| Jul 15, 2026 | 2.69M | 7.80% | -6% | 350,194 | 7.7 |
| Jun 30, 2026 | 2.87M | 8.31% | -13% | 591,071 | 4.8 |
| Jun 15, 2026 | 3.30M | 9.55% | +6% | 624,073 | 5.3 |
| May 29, 2026 | 3.11M | 9.01% | -9% | 421,197 | 7.4 |
| May 15, 2026 | 3.43M | 9.94% | -3% | 542,433 | 6.3 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Delcath Systems company events
Delcath Systems filed 9 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 9, 2026.
- Nov 9, 2026ResultsReleased financial results. Filing
- Aug 14, 2026RulesChanged its bylaws or articles. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- May 14, 2026LeadershipOmnibus Equity Incentive Plan At the 2026 annual meeting of stockholders held on May 13, 2026, the stockholders of Delcath Systems, Inc. approved an amendment to the Company’s 2020 Omnibus Equity Incentive Plan to increase by 1,800,000 the number of shares of the Company’s common stock, $0.01 par… Filing
- May 7, 2026ResultsReleased financial results. Filing
- Mar 3, 2026AnnouncementDelcath Systems, Inc. issued a press release announcing publication of CHOPIN clinical trial results in the Lancet Oncology. Filing
- Feb 26, 2026ResultsReleased financial results. Filing
- Jan 12, 2026AnnouncementDelcath disclosed in the Corporate Presentation that as of December 31, 2025, (i) it had a total of 25 active sites utilizing HEPZATO KIT and (ii) there were approximately 34.7 million shares of its common stock issued and outstanding. Filing
- Nov 20, 2025AnnouncementThe board of directors of Delcath Systems, Inc., a Delaware corporation authorized a share repurchase program under which the Company may repurchase up to $25 million of its outstanding shares of common stock from time to time, subject to market conditions. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Delcath Systems financials
Famous investors that hold DCTH
4 of the 50 well-known investors we track reported holding DCTH in their latest 13F filing. The largest position is Israel Englander's, worth $9.7M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 608,023 | $9.7M | 0.0% | +7% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 168,318 | $2.7M | 0.0% | +1298% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 69,178 | $1.1M | 0.0% | +360% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 61,977 | $990K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named DCTH in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 12, 2026 | Daniel Kaufman | 13G/A | 2.9% |
| Nov 12, 2026 | Daniel Kaufman | 13G/A | 2.9% |
| Oct 27, 2026 | BlackRock Portfolio Management LLC | 13G | 6.3% |
| Oct 27, 2026 | BlackRock Portfolio Management LLC | 13G | 6.3% |
| Oct 19, 2026 | Rosalind Advisors, Inc. | 13D/A | 9.9% |
| Oct 19, 2026 | Rosalind Advisors, Inc. | 13D/A | 9.9% |
Questions about Delcath Systems, Inc. (DCTH) stock
Who owns the most DCTH stock?
The largest reported owner of Delcath Systems, Inc. (DCTH) is Rosalind Advisors, Inc., with 9.6% of the company. In total, 120 funds and institutions reported holding DCTH at the end of Q2 2026, together about 51% of the shares. See the largest owners.
Are DCTH insiders buying or selling?
In the last 12 months, DCTH insiders reported 3 open-market purchases worth $189K and 2 sales worth $489K. The latest trade was on Nov 12, 2026. See every trade.
What is the short interest in DCTH?
As of Oct 30, 2026, 1.78M DCTH shares were sold short, 5.1% of the shares outstanding, down 5.7% from the report before. At the average daily volume of 309,358 shares, buying them all back would take about 5.7 trading days (days to cover). See the history.
Which famous investors hold DCTH?
4 of the 50 well-known investors we track reported DCTH in their latest 13F filing, including Israel Englander, Paul Tudor Jones, Ken Griffin. The largest position is worth $9.7M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.